Dr. Mashid was professional, knowledgeable, and friendly. The office ran smoothly and was on time.
— leah davis
Diabetic retinopathy can affect anyone living with diabetes, and its impact is widespread. Knowing your personal risk factors helps you and your care team stay ahead of the condition.
Anyone with type 1, type 2, or gestational diabetes, a form of diabetes that can develop during pregnancy, is at risk. The longer a person has lived with diabetes, the greater the risk of developing some degree of retinal damage. Over time, more than half of people with diabetes will develop diabetic retinopathy to some extent.
Certain factors increase the likelihood that diabetic retinopathy will develop or worsen over time.
Women with diabetes who become pregnant face a heightened risk of diabetic retinopathy progressing more quickly. Hormonal changes and shifts in blood sugar during pregnancy can accelerate retinal damage. If you have diabetes and are pregnant or planning to become pregnant, a dilated eye exam should be scheduled as soon as possible. Our retina specialists can monitor your eyes throughout pregnancy and recommend treatment if needed.
One of the most dangerous aspects of diabetic retinopathy is that it can cause significant damage before you notice any vision changes. Knowing both the subtle and serious signs helps you seek care at the right time.
In the early stages of diabetic retinopathy, most people experience no symptoms at all. Some may notice occasional difficulty reading, mild blurring, or trouble seeing objects at a distance. These changes can be easy to dismiss, which is why routine exams are so important even when your vision feels normal.
As the condition progresses, more noticeable changes can occur. Bleeding into the vitreous may cause dark spots, streaks, or web-like floaters drifting across your vision. If the macula is affected by swelling, central vision may become blurry or distorted, making reading and recognizing faces difficult.
Some symptoms indicate a sight-threatening emergency and should never be ignored. If you experience any of the following, contact our office immediately or go to the nearest emergency room.
These symptoms can signal a vitreous hemorrhage or retinal detachment, both of which require prompt evaluation and treatment.
Accurate diagnosis is the foundation of effective treatment. Our retina clinic uses advanced imaging technology to detect and monitor diabetic retinopathy with precision.
A dilated eye exam is the most essential tool for detecting diabetic retinopathy. Special drops are used to widen your pupils, allowing the retina specialist to examine the back of the eye clearly. During the exam, the specialist looks for leaking or abnormal blood vessels, retinal swelling, fatty deposits on the retina, and any signs of scar tissue or new blood vessel growth. Because diabetic retinopathy can be present without symptoms, this exam is critical for everyone with diabetes, even when vision seems fine.
OCT is a painless, non-invasive imaging scan that produces detailed cross-section images of the retina. It measures retinal thickness and detects fluid buildup in the macula, making it especially valuable for diagnosing and tracking diabetic macular edema. The test takes only a few minutes and helps our specialists assess exactly how the retina is responding to treatment over time.
Fluorescein angiography involves injecting a small amount of yellow dye into a vein, which then travels through the blood vessels in the eye. A specialized camera captures rapid photographs as the dye flows through retinal circulation. This reveals areas where vessels are leaking, blocked, or growing abnormally. ICG (indocyanine green) angiography uses a different dye to examine the deeper layers of blood vessels beneath the retina. Together, these tests help our specialists plan the most targeted and effective treatment approach.
B-scan echography uses sound waves to create images of the inside of the eye and is particularly useful when bleeding or other conditions make it difficult to see the retina directly. Color fundus photography creates detailed photographic images of the retina that can be compared over time to track changes in the disease. These tools give our team a complete picture of your retinal health at every stage of care.
Treatment for diabetic retinopathy has advanced considerably, and today there are more effective options than ever before. Our visiting retina specialists tailor every treatment plan to the individual patient's needs and stage of disease.
Anti-VEGF injections are the most widely used treatment for diabetic retinopathy and diabetic macular edema. These medications are delivered directly into the vitreous cavity of the eye and work by blocking VEGF, the chemical signal that drives abnormal vessel growth and fluid leakage. Research consistently shows that anti-VEGF therapy often leads to better vision outcomes than laser treatment alone for DME. Several FDA-approved medications are used, including aflibercept (Eylea), high-dose aflibercept (Eylea HD), ranibizumab (Lucentis), faricimab (Vabysmo), and bevacizumab (Avastin, used off-label). The choice of medication and dosing interval is guided by how each patient responds to treatment.
Laser photocoagulation uses a precisely focused thermal laser applied to the retina to reduce the oxygen demand of retinal tissue and slow the progression of abnormal blood vessel growth. Panretinal photocoagulation, or PRP, applies hundreds of small laser spots to the peripheral retina and is used primarily for proliferative diabetic retinopathy. Focal laser treatment can target specific areas of leakage near the macula. While anti-VEGF injections have become the preferred first-line therapy for DME, laser treatment remains an important option for certain cases of proliferative disease.
Vitrectomy is a surgical procedure in which the retina specialist removes the vitreous gel from inside the eye. It is recommended for advanced diabetic retinopathy when significant bleeding into the vitreous does not clear on its own, or when scar tissue is pulling on the retina and threatening to cause a detachment. During surgery, the vitreous is replaced with a saline solution or gas bubble to support the retina's position. Our vitreoretinal surgeons are fellowship-trained and experienced in managing complex retinal disease requiring this level of intervention.
For some patients, sustained-release drug delivery systems offer an alternative to frequent injections. Susvimo, a small implant placed inside the eye, continuously releases ranibizumab and requires refills approximately every nine months rather than monthly visits. Steroid-based implants such as the dexamethasone implant (Ozurdex) can also be used for DME, particularly in patients who do not respond adequately to anti-VEGF therapy. Our specialists will discuss which approach is most appropriate based on your clinical situation.
Biosimilars are medications that are highly similar to FDA-approved biologic drugs and have undergone rigorous testing to confirm their safety and effectiveness. Options such as Ahzantive (aflibercept-mrbb), Byooviz (ranibizumab-nuna), and Cimerli (ranibizumab-eqrn) are available and may be used as part of your treatment plan. These medications expand the range of available therapies and may offer additional flexibility in how your care is structured.
Understanding what happens at each stage of care helps reduce anxiety and allows you to be an active participant in protecting your vision. Our team walks every patient through their treatment plan before and during each visit.
Intravitreal injections are performed in our office and take only a few minutes from start to finish. The eye is numbed with anesthetic drops, and the surface is cleaned with an antiseptic solution before the injection. Most patients feel a sensation of pressure rather than sharp pain, and the injection itself takes only a few seconds. Mild redness, irritation, or floaters may occur afterward but typically resolve within a few days.
Treatment for diabetic retinopathy is typically a long-term commitment rather than a one-time event. Anti-VEGF injections are often given monthly during an initial loading phase, with intervals gradually extended based on how the eye responds. Your retina specialist will monitor your progress through regular exams and OCT scans at every follow-up visit. Consistent attendance at scheduled appointments is one of the most important things you can do to maintain your vision.
Treatment is designed to stabilize vision and, in many cases, improve it. However, outcomes vary from person to person, and damage that has already occurred to the retina may not be fully reversible. The primary goal is to prevent further vision loss and preserve as much functional sight as possible. Starting treatment early and maintaining consistent care gives you the strongest foundation for a favorable outcome.
Managing diabetic retinopathy extends beyond your eye appointments. The daily choices you make about your overall health directly affect the health of your retina.
Keeping blood sugar, blood pressure, and cholesterol within recommended ranges is the most powerful step you can take to slow the progression of diabetic retinopathy. Work closely with your primary care physician or endocrinologist to stay within your target blood sugar range. Even modest improvements in blood sugar control over time can produce meaningful benefits for your eyes.
Because diabetic retinopathy can worsen silently, annual dilated eye exams are essential for everyone with diabetes, even when vision feels perfectly normal. Your retina specialist may recommend more frequent visits depending on the severity of your condition or if your systemic health changes. Staying on schedule with exams ensures that any progression is caught and treated as early as possible.
Eating a balanced diet, staying physically active, maintaining a healthy weight, and avoiding tobacco all support better blood sugar control and reduce the risk of worsening retinal damage. If you have experienced some vision loss, low-vision aids such as magnifying devices, large-print materials, and improved lighting can help you maintain independence in daily activities.
These answers address common concerns that go beyond the general information covered above and are meant to help you make informed decisions about your care.
While treatment can meaningfully improve vision for many patients, not all retinal damage can be undone. The extent of recovery depends on how much damage occurred before treatment began and how well the eye responds to therapy. This is one of the strongest reasons to begin monitoring and treatment early, before significant structural damage has taken place. Consistent care over time gives your eye the best opportunity to maintain as much vision as possible.
The frequency of injections depends on the medication used, the severity of your condition, and how your eye responds over time. Some newer medications allow treatment intervals of 8 to 16 weeks once your condition has stabilized. Treatment is often ongoing rather than finite, but the schedule is continuously reassessed and adjusted at each visit. Your retina specialist will explain what to expect at the beginning of your treatment and update the plan as your eye's response becomes clear.
Without treatment, diabetic retinopathy can advance to stages that cause permanent and severe vision loss. Proliferative diabetic retinopathy can lead to bleeding inside the eye, traction retinal detachment, and a condition called neovascular glaucoma, in which dangerously high eye pressure causes pain and further vision damage. These complications are far more difficult to treat than the earlier stages of the disease. Timely evaluation and ongoing treatment are the most effective way to prevent these serious outcomes.
Diabetic retinopathy commonly develops in both eyes over time, though the severity may differ between them. One eye may be at an earlier or more advanced stage than the other, which is why a complete dilated exam of both eyes is performed at every visit. Treatment plans are individualized for each eye based on the level of disease present, so one eye may require more frequent or intensive treatment than the other at any given time.
Yes, and this is one of the most important points about diabetic retinopathy. Significant damage can occur and worsen for months or years before any vision change is noticeable. By the time symptoms appear, the window for the most effective treatment may have narrowed. Annual exams allow your retina specialist to detect changes in the retina at a stage when intervention is most likely to preserve your sight long-term.
Your primary care doctor or optometrist can coordinate your routine diabetes-related eye exams, but a referral to a retina specialist is appropriate when diabetic retinopathy has been detected, when you have had diabetes for a number of years, or when your blood sugar control has been difficult to manage. Any sudden change in vision, including new floaters, flashing lights, or a shadow in your visual field, should be evaluated by a retina specialist without delay. Women with diabetes who are pregnant or planning a pregnancy should also see a retina specialist early, as pregnancy can accelerate retinal changes.
Our visiting retina specialists bring fellowship-level expertise in vitreoretinal surgery, medical retina, and uveitis care to patients throughout Northern Virginia at our retina clinic in Lansdowne. Whether you need a baseline evaluation, ongoing monitoring, or treatment for an advanced case, The Eye Center is equipped to provide the comprehensive retinal care you deserve. We encourage every patient with diabetes to take the first step toward protecting their sight by scheduling an appointment with our team.